Skip to content

Released Aug 5, 2021, after the close

10-Q filed Aug 5, 2021, 36 days after period end · 0001564590-21-041680

Q2 2021 · 10-Q
Revenue—
Net Income-$23.60MN/M vs Q2 2020N/M vs Q1 2021
EPS Diluted-$0.55N/M vs Q2 2020N/M vs Q1 2021
Operating Income-$23,666,000N/M
Operating Cash Flowderived-$21,808,000N/M
Free Cash Flowderived-$21,808,000N/M

What the release said

The release

Same quarter

MetricQ2 2021Q2 2020Q2 2019Q2 2018
Revenue—$39.38M$3.08M$3.22M
Net Income-$23.60M$7.27M-$18.50M-$26.81M
EPS Diluted-$0.55$0.19-$0.72-$1.30

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR